Archives

  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Nigeria currently has three PBCRs and HBCRs Most of

    2020-08-28


    Nigeria currently has three PBCRs and 21 HBCRs.18 Most of these registries are functioning with very limited resources. In light of these facts, the cancer burden in Nigeria is likely underestimated.19,20 The establishment and maintenance of cancer registries has proven challenging for a variety of rea-sons: resource and health insurance limitations restricting the
    Fig. 2 e Distribution of diseases at different sites. (Color version of figure is available online.) 
    Fig. 3 e Distribution of cancer stage presentation. (Color version of figure is available online.)
    population from accessing health care facilities, lack of trained personnel, and inadequate funding for cancer control efforts at government levels. In addition, there is an under-appreciation of the cancer burden, thus an underappreciation of the role registries play in alleviating such a burden.18,21-23
    Cancer control is defined by the World Health Organization (WHO) to consist the following: prevention, early detection, diagnosis/treatment, pain relief/palliative care, cancer control research, and surveillance.9 Lakeshore Cancer Center, the first facility in Nigeria, dedicated solely to cancer prevention and treatment, has been making efforts to address all these ele-ments of cancer control. To expand our efforts, we have begun the preliminary stages of establishing a hospital-based cancer registry at LCC.
    As the sole facility in Lagos focused on cancer care, LCC considers a core part of its mission to promote and support cancer registration in this region. Currently, Lagos Nocodazole has two teaching hospitals that have HBCRs. However, with multiple competing priorities, cancer registration is typically under-funded in these hospitals. LCC has the potential to attract greater funding for cancer registration in the region. With the three centers pooling their resources and efforts, the establishment of a collaborative PBCR in the Lagos region will become feasible.
    The current registry platform utilized by these hospitals is Can Reg. Thus, it Nocodazole became the optimal platform to build our registry on. However, it proved to have its challenges. The program was not always responsive, and technical issues could not be readily resolved. Technical support for this pro-gram is limited to a small working group in France. To resolve this, we aligned ourselves with Nigerian National System of Cancer Registries. They provided technical support for Can Reg and trained staff members to become cancer registrars. The program is now fully operational, and data collection has been ongoing for 2 y. To ensure data validity, we worked with a public health consulting firm who assisted us in creating a comprehensive data management system. They also per-formed an internal audit of our current cancer registry data. As we acquire more data, follow-up studies such as survival will be part of our future focus.
    Education, prevention, and early detection remain key el-ements of cost effective cancer control in Nigeria, as in most LMICs. PBCRs will greatly facilitate these efforts. As we continue our cancer control efforts, national cancer advocacy should promote public cancer awareness and foster a greater allocation of federal resources to ionic bond cause. Ultimately, these
    efforts should result in a greater proportion of cancers being detected in earlier stages where treatment is much more effective and survival is greater.
    Acknowledgment
    This work was supported by the National Cancer Institute of the National Institute of Health under the grant number R25CA181003.
    Authors’ contributions: Study concept and design were carried out by M.F., C.N., and S.E. Acquisition of data and analysis was carried out by M.F., B.C., and I.E. Interpretation of data was carried out by M.F. and C.N. Drafting of the article, critical revision of the article, and final approval were done by M.F., A.S., C.N., and M.M.
    Disclosure
    The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
    2. Hanna TP, Kangolle AC. Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int Health Hum Rights. 2010;10:24.
    4. Bouchardy C, Rapiti E, Benhamou S. Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths. Ecancermedicalscience. 2014;8:413e418.
    5. Compton, C., Byrd, D., & Garcia-Aguilar, J. et al AJCC cancer staging Atlas - cancer survival analysis.
    6. Cancer Registries. Why, What and How?. Retrieved from http://www.uicc.org/sites/main/files/private/UICC%20Cancer %20Registries-%20why%20what%20how.pdf.